Patient dies following muscular dystrophy gene therapy, Sarepta reports

by

Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular dystrophy, sending company shares plummeting in morning trading.

Leave A Comment

Your email address will not be published. Required fields are marked *